Rosenheim, Joshua https://orcid.org/0000-0003-0171-2053
Gupta, Rishi K. https://orcid.org/0000-0002-6257-1285
Thakker, Clare
Mann, Tiffeney
Bell, Lucy C. K. https://orcid.org/0000-0002-1762-7294
Broderick, Claire M. https://orcid.org/0000-0003-2582-4527
Madon, Kieran
Papargyris, Loukas https://orcid.org/0000-0002-5803-5826
Dayananda, Pete
Kwok, Andrew J. https://orcid.org/0000-0001-8928-5054
Greenan-Barrett, James
Wagstaffe, Helen R. https://orcid.org/0000-0002-4462-7484
Conibear, Emily https://orcid.org/0000-0002-3445-6992
Fenn, Joe https://orcid.org/0000-0003-1166-7831
Hakki, Seran https://orcid.org/0000-0003-0554-339X
Lindeboom, Rik G. H.
Dratva, Lisa M. https://orcid.org/0000-0002-2873-6787
Lemetais, Briac
Weight, Caroline M. https://orcid.org/0000-0001-6235-550X
Venturini, Cristina
Kaforou, Myrsini https://orcid.org/0000-0001-9878-4007
Levin, Michael https://orcid.org/0000-0003-2767-6919
Kalinova, Mariya
Mann, Alex J. https://orcid.org/0000-0002-3744-4604
Catchpole, Andrew https://orcid.org/0000-0003-1795-1008
Knight, Julian C. https://orcid.org/0000-0002-0377-5536
Nikolić, Marko Z. https://orcid.org/0000-0001-6304-6848
Teichmann, Sarah A. https://orcid.org/0000-0002-6294-6366
Killingley, Ben
Barclay, Wendy https://orcid.org/0000-0002-3948-0895
Chain, Benjamin M. https://orcid.org/0000-0002-7417-3970
Lalvani, Ajit
Heyderman, Robert S. https://orcid.org/0000-0003-4573-449X
Chiu, Christopher https://orcid.org/0000-0003-0914-920X
Noursadeghi, Mahdad https://orcid.org/0000-0002-4774-0853
Funding for this research was provided by:
Wellcome Trust (224530/Z/21/Z, 207511/Z/17/Z, 102186/B/13/Z)
DH | National Institute for Health Research (NIHR200927, NIHR302829)
Action Medical Research (GN2911)
RCUK | Medical Research Council (MR/5005579/1)
Article History
Received: 21 July 2023
Accepted: 19 November 2024
First Online: 30 November 2024
Competing interests
: The Authors declare the following competing interests: In the past 3 years, S.A.T. has received remuneration for scientific advisory board membership from Sanofi, GlaxoSmithKline, Foresite Labs and Qiagen. S.A.T. is a co-founder and holds equity in Transition Bio and Ensocell. From 8 January 2024, S.A.T. has been a part-time employee of GlaxoSmithKline. A.J.M., A.C., M.K., M.M. and A.B. are full time employees at hVIVO Services Ltd. No other authors report any competing interests.